ctDNA Tumor Fraction Predicts Who Needs Chemotherapy Added to Immunotherapy in Lung Cancer
The longstanding clinical puzzle of when to add chemotherapy to immunotherapy in advanced lung cancer may have a more precise molecular answer. For the…
Found 2067 results for "cancer"
The longstanding clinical puzzle of when to add chemotherapy to immunotherapy in advanced lung cancer may have a more precise molecular answer. For the…
For the roughly 70–80% of hepatocellular carcinoma patients who experience tumor recurrence within five years of surgery, the window for intervention is…
For decades, the idea of teaching the immune system to recognize and destroy a patient's own tumor has been more promise than reality — but the therapeutic…
The quality of cancer outcomes research depends almost entirely on the accuracy and completeness of clinical registries — and those registries are riddled…
Among 32 matched cohort pairs of breast cancer survivors in the Stockholm-Gotland region (2008–2019), women carrying germline BRCA1/2 mutations experienced…
Understanding why breast cancer returns years after apparent remission is one of oncology's most vexing problems. This research reframes that question…
One of oncology's most persistent puzzles is how MYC — the transcription factor gone rogue in virtually every human tumor — can simultaneously damage DNA and…
At a strikingly low concentration of 0.1 μM — far below typical supplementation doses — resveratrol completely rescued ionizing radiation (IR)-induced DNA…
Across 126 studies enrolling more than 8 million participants, greater adherence to the Mediterranean diet was associated with statistically significant…
Understanding why some liver cancers grow aggressively while resisting natural cell-death signals has been a persistent challenge in oncology. The discovery…
Chronic lung disease is not simply wear and tear — it is aging biology gone awry in specific, targetable ways. As pulmonary medicine reaches a point where…
Liver cancer remains one of the most lethal malignancies precisely because it is so rarely caught early. If a standard clinical visit — the kind millions of…
In aged male Wistar rats, eight weeks of moderate-intensity resistance training combined with a multi-nutrient stack (Lactobacillus plantarum, Bifidobacterium…
Acquired resistance to first-line therapies remains one of the most stubborn barriers in advanced liver cancer treatment. Understanding exactly how tumor…
For patients with advanced melanoma who have exhausted standard immune checkpoint inhibitor options, the prospect of meaningful, durable remissions has…
The prospect of a single AI system capable of reading pathology slides and answering clinical questions at physician-grade accuracy — without being retrained…
Surviving childhood cancer is rightly celebrated — but the long shadow it casts on adult neurocognitive and psychological health is only beginning to be…
The boundary between immune tolerance and immune attack is finely calibrated by a small population of regulatory T cells (Tregs), and disrupting that balance…
For the estimated 1-2% of the global population living with vitiligo, narrowband UVB phototherapy offers meaningful hope for repigmentation — yet the same…
One of the most stubborn obstacles in brain cancer treatment is not the tumor itself — it is the blood-brain barrier, a molecular fortress that blocks roughly…